Colombia’s Ministry of Health of Colombia sounded an official warning about the possible outbreak of a dengue epidemic in the country in early 2019. National Institute of Health estimates said the possible number of cases could reach 120,000 over the course of 2019, compared with previous epidemics in 2016 (101,016 recorded cases), in 2013 (125,554) and in 2010 (156,977).
Analgesics is one of the products with the highest rates of illegal sales in the country, according to INVIMA (National Institute of Food and Drug Surveillance). INVIMA said that it has eliminated more than 9,000 e-commerce platforms selling illegal pharmaceutical products.
A daily dose of aspirin is no longer recommended as a preventative for healthy people after research and studies showed that the health risks might outweigh the benefits. With aspirin associated with possibly causing bleeding or even haemorrhaging, the thinking is now that it should not be given to older adults who do not have a high risk of or existing heart disease.
When launching its new Multidol brand Chalver de Colombia made sure that it met the new regulations laid down by INVIMA. The law on this type of medication defines a limit of milligrams for each pill for it to be considered OTC or RX.
Analgesics under well-known brands are still likely to be preferred by consumers in Colombia as well as more likely to be recommended by pharmacists than generics, even though generic drugs have the same effectiveness as branded products and can be significantly cheaper.
Foreign players maintained the leading positions in analgesics in Colombia in 2019, with leading player GSK Consumer Healthcare alone accounting for almost half of total retail value sales, thanks mainly to its popular Dolex and Advil brands. Advil was still under Pfizer as its NBO and GBO until last year, but is now under GSK, following the two companies’ merging of their consumer healthcare businesses.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Colombia with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in Colombia, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in Colombia market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.